The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys

Published:2016-04-22 Issue:6 Volume:254 Page:1117-1125
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Ludinsky Maximilian,Christner Sarah,Su Nan,Taubitz Tatjana,Tschulakow Alexander,Biesemeier Antje,Julien-Schraermeyer Sylvie,Schraermeyer Ulrich

Funder

Novartis Pharma

STZ OcuTox Preclinical Drug Assessment

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-016-3344-8.pdf

Reference54 articles.

1. Tah V, Orlans HO, Hyer J, Casswell E, Din N, Sri Shanmuganathan V, Ramskold L, Pasu S (2015) Anti-VEGF therapy and the retina: an update. J Ophthalmol: 627674. doi 10.1155/2015/627674

2. Bikbov MM, Babushkin AE, Orenburkina OI (2012) Anti-VEGF-agents in treatment of neovascular glaucoma. Vestn Oftalmol 128:50–53

3. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU, Tuebingen Bevacizumab Study G (2006) Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 142:158–160. doi: 10.1016/j.ajo.2006.02.045

4. Tolentino M (2011) Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv Ophthalmol 56:95–113. doi: 10.1016/j.survophthal.2010.08.006

5. Barkmeier AJ, Akduman L (2009) Bevacizumab (Avastin) in ocular processes other than choroidal neovascularization. Ocul Immunol Inflamm 17:109–117. doi: 10.1080/09273940802596534

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel regulators of airway epithelial barrier function during inflammation: potential targets for drug repurposing;Expert Opinion on Therapeutic Targets;2022-02-01

2. Management of patients with operated refractory neovascular glaucoma (clinical observation);Meditsinskiy sovet = Medical Council;2021-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3